INBX vs MPWR · rev $1.3M vs P/E 112, rev $1.78B
Inhibrx Biosciences, Inc. (INBX) versus Monolithic Power Systems Inc (MPWR) — a side-by-side from cached financials, not a winner call.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Monolithic Power Systems Inc (MPWR) is a semiconductors company listed on US.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
Latest reported MPWR revenue for 2026-06-30 was $1.78B. Net income was $450.5M. MPWR currently screens at market cap $77.49B and trailing P/E 112.3.
INBX currently screens at market cap $1.28B. MPWR currently screens at market cap $77.49B and trailing P/E 112.3.
Not investment advice. Open the INBX and MPWR stock pages for the full models.
Not investment advice.